imageResearch & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship
image

Research & Discovery

A Blog Devoted to UD Innovation, Excellence and Scholarship

ABOVE: Eleftherios (Terry) Papoutsakis is the Unidel Eugene du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware.

With $1.5 million grant, UD engineers study microbes for biofuel production

A group of bacteria best known for causing stomach trouble could also be a source of sustainable energy.

The U.S. Department of Energy has awarded Eleftherios (Terry) Papoutsakis a three-year, $1.5 million grant to study the production of clostridium bacteria as platforms for biofuels. Papoutsakis, the Unidel Eugene du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware, will uncover fundamental insights about metabolism and environmental signaling in these microbes for use to produce fuels from renewable resources.

Papoutsakis has been studying clostridium bacteria for more than four decades. He was elected to the National Academy of Engineering in 2018 in part for his work with these microbes.

Clostridia are anaerobic bacteria that can be found in many environments that lack oxygen, from soil to parts of the human body. As these bacteria digest their food, which includes carbohydrates, proteins and many other molecules, they produce compounds such as butanol, acetone and ethanol, which are useful to makers of industrial chemicals and biofuels. Over the past few years, Papoutsakis has been utilizing unique combinations of bacteria to optimize this mix of metabolites.

UD Research on Twitter

TOP STORIES

Protecting buildings from earthquakes

Engineering professor studies effectiveness of retrofits to strengthen concrete structures

atomic clock

Minding the atomic clock

UD professor helps test the symmetry of space-time

Ammon Pinizzotto Biopharmaceutical Innovation Building

NIIMBL gets $8.9 million for COVID-19 response

UD-based national institute will address testing, diagnostics, supply chain and vaccine manufacturing